Skip to main content
OpenTrials

Clinical trial condition

Retinopathy of Prematurity (ROP)

Explore clinical trials studying Retinopathy of Prematurity (ROP). Study availability and eligibility vary by location and protocol.

22 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Retinopathy of Prematurity (ROP) trial results

Completed

Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090

NCT04015180

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Infant, Newborn, Diseases, +4 more
Locations
  • Hospital Público Descentralizado "Dr. Guillermo Rawson" San Juan, Argentina
  • AZ Sint Jan Brugge - Ophthalmology Bruges, Belgium
  • Hospital das Clínicas de Botucatu - UNESP Botucatu Botucatu, São Paulo, Brazil
  • Unifesp/Epm São Paulo, Brazil
View all 55 locations
View Trial Details
Completed

Rainbow Extension Study

NCT02640664

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Infant, Newborn, Diseases, +4 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Louisville, Kentucky, United States
View all 73 locations
View Trial Details
Completed

Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)

NCT02386839

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Infant, Newborn, Diseases, +4 more
Locations
  • University of South Alabama Children's and Women's Hospital Mobile, Alabama, United States
  • Vidant Medical Center Greenville, North Carolina, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • University of Wisconsin - Madison Madison, Wisconsin, United States
View all 16 locations
View Trial Details
Completed

Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy

NCT04004208

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Infant, Newborn, Diseases, +4 more
Locations
  • Many Locations Multiple Locations, Argentina
  • Hospital Público Descentralizado "Dr. Guillermo Rawson" San Juan, Argentina
  • Kepler Universitätsklinikum Campus III Linz, Austria
  • Many Locations Multiple Locations, Austria
View all 90 locations
View Trial Details
Completed

IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

NCT01096784

Conditions
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +9 more
Locations
  • University of South Alabama Children's and Women's Hospital Mobile, Alabama, United States
  • Univ of California Irvine Med Center Irvine, California, United States
  • Georgia Regents Medical Center Augusta, Georgia, United States
  • Univ of Mississippi Medical Center Jackson, Mississippi, United States
View all 24 locations
View Trial Details

Related conditions